These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31699406)

  • 21. Dr.Nod: computational framework for discovery of regulatory non-coding drivers in tissue-matched distal regulatory elements.
    Tomkova M; Tomek J; Chow J; McPherson JD; Segal DJ; Hormozdiari F
    Nucleic Acids Res; 2023 Feb; 51(4):e23. PubMed ID: 36625266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic selection distinguishes oncogenes and tumor suppressor genes.
    Chandrashekar P; Ahmadinejad N; Wang J; Sekulic A; Egan JB; Asmann YW; Kumar S; Maley C; Liu L
    Bioinformatics; 2020 Mar; 36(6):1712-1717. PubMed ID: 32176769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel hypergraph model for identifying and prioritizing personalized drivers in cancer.
    Zhang N; Ma F; Guo D; Pang Y; Wang C; Zhang Y; Zheng X; Wang M
    PLoS Comput Biol; 2024 Apr; 20(4):e1012068. PubMed ID: 38683860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of cancer driver genes based on nucleotide context.
    Dietlein F; Weghorn D; Taylor-Weiner A; Richters A; Reardon B; Liu D; Lander ES; Van Allen EM; Sunyaev SR
    Nat Genet; 2020 Feb; 52(2):208-218. PubMed ID: 32015527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individualized discovery of rare cancer drivers in global network context.
    Petrov I; Alexeyenko A
    Elife; 2022 May; 11():. PubMed ID: 35593700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery.
    Hudson AM; Yates T; Li Y; Trotter EW; Fawdar S; Chapman P; Lorigan P; Biankin A; Miller CJ; Brognard J
    Cancer Res; 2014 Nov; 74(22):6390-6396. PubMed ID: 25256751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep phylogeny of cancer drivers and compensatory mutations.
    Rochman ND; Wolf YI; Koonin EV
    Commun Biol; 2020 Oct; 3(1):551. PubMed ID: 33009502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts.
    Jiang L; Zheng J; Kwan JSH; Dai S; Li C; Li MJ; Yu B; To KF; Sham PC; Zhu Y; Li M
    Nucleic Acids Res; 2019 Sep; 47(16):e96. PubMed ID: 31287869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel ratio-metric features enable the identification of new driver genes across cancer types.
    Sudhakar M; Rengaswamy R; Raman K
    Sci Rep; 2022 Jan; 12(1):5. PubMed ID: 34997044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current topics in mutations in the cancer genome].
    Iwaya T; Mimori K; Wakabayashi G
    Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):185-90. PubMed ID: 22582578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DeepAlloDriver: a deep learning-based strategy to predict cancer driver mutations.
    Song Q; Li M; Li Q; Lu X; Song K; Zhang Z; Wei J; Zhang L; Wei J; Ye Y; Zha J; Zhang Q; Gao Q; Long J; Liu X; Lu X; Zhang J
    Nucleic Acids Res; 2023 Jul; 51(W1):W129-W133. PubMed ID: 37078611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SB Driver Analysis: a Sleeping Beauty cancer driver analysis framework for identifying and prioritizing experimentally actionable oncogenes and tumor suppressors.
    Newberg JY; Black MA; Jenkins NA; Copeland NG; Mann KM; Mann MB
    Nucleic Acids Res; 2018 Sep; 46(16):e94. PubMed ID: 29846651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era.
    Porta-Pardo E; Valencia A; Godzik A
    FEBS Lett; 2020 Dec; 594(24):4233-4246. PubMed ID: 32239503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interpreting pathways to discover cancer driver genes with Moonlight.
    Colaprico A; Olsen C; Bailey MH; Odom GJ; Terkelsen T; Silva TC; Olsen AV; Cantini L; Zinovyev A; Barillot E; Noushmehr H; Bertoli G; Castiglioni I; Cava C; Bontempi G; Chen XS; Papaleo E
    Nat Commun; 2020 Jan; 11(1):69. PubMed ID: 31900418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features.
    Buisson R; Langenbucher A; Bowen D; Kwan EE; Benes CH; Zou L; Lawrence MS
    Science; 2019 Jun; 364(6447):. PubMed ID: 31249028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-generation sequencing of oncogenes and tumor suppressor genes in odontogenic myxomas.
    Santos JN; Sousa Neto ES; França JA; Diniz MG; Moreira RG; Castro WH; Gomez RS; de Sousa SF; Gomes CC
    J Oral Pathol Med; 2017 Nov; 46(10):1036-1039. PubMed ID: 28597929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of cancer driver mutations in protein kinases.
    Torkamani A; Schork NJ
    Cancer Res; 2008 Mar; 68(6):1675-82. PubMed ID: 18339846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
    Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
    Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Driver gene classification reveals a substantial overrepresentation of tumor suppressors among very large chromatin-regulating proteins.
    Waks Z; Weissbrod O; Carmeli B; Norel R; Utro F; Goldschmidt Y
    Sci Rep; 2016 Dec; 6():38988. PubMed ID: 28008934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.